Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 11 Apr 2025

OAS Family Activation Drives Esophageal Cancer Progression: A Pan-Cancer Tumor Microenvironment and Immunotherapy Responsiveness Analysis

in Cancer Immunity and Immunotherapy

Danwen Zhao
Shihui Chen
Chen Xiaoya
Tonghui Xie
Jintao Chai
Changchun Ye
Shiyuan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578909

Systematic Review

Published on 11 Apr 2025

A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy

in Cancer Immunity and Immunotherapy

Zixu Liu
Yuchen Mao
Shukai Wang
Haoyu Zheng
Kangping Yang
Liang Yang
Peng Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1566227

370 views

Review

Published on 11 Apr 2025

From surfing to diving into the tumor microenvironment through multiparametric imaging mass cytometry

in Cancer Immunity and Immunotherapy

Marco Erreni
Maria Rita Fumagalli
Matteo Marozzi
Roberto Leone
Raffaella Parente
Raffaella D’Anna
Andrea Doni

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544844

495 views

Original Research

Published on 11 Apr 2025

CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study

in Cancer Immunity and Immunotherapy

Jingwei Yu
Xiuhua Sun
Guangxun Gao
Li Yu
Jiesong Wang
Lihua Qiu
Zhengzi Qian
Wei Li
Huilai Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551723

861 views

Review

Published on 11 Apr 2025

Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy

in Cancer Immunity and Immunotherapy

Jiahuan Wei
Daozhang Li
Haixia Long
Mei Han

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562797

318 views

Original Research

Published on 11 Apr 2025

Multi-sequence MRI based radiomics nomogram for prediction expression of programmed death ligand 1 in thymic epithelial tumor

in Cancer Immunity and Immunotherapy

Jie Shen
Lantian Zhang
Shuke Li
Xiaofei Mu
Tongfu Yu
Wei Zhang
Yue Yu
Jing He
Wen Gao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555530

163 views

Original Research

Published on 11 Apr 2025

Suppressor effects of carrots on azoxymethane/dextran sulfate sodium-induced colon cancer according to cultivation method

in Cancer Immunity and Immunotherapy

Yanni Pan
Yeon-Jun Lee
Jin Hyeop Kim
Min Ji Song
KyuBum Kwack
Seung-Hwan Park
Sin-Il Sin
Ji Hyung Chung
Kun-Young Park

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554801

281 views

Review

Published on 11 Apr 2025

Immunotherapy in gestational trophoblastic neoplasia: advances and future directions

in Cancer Immunity and Immunotherapy

Jing Zeng
Jing Zhang
Jianzhang Wang
Lian Xu
Cheng Wang
Rutie Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544585

231 views

Original Research

Published on 11 Apr 2025

Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Xiaobin Cao
Jing Li
Siyu Liu
Aichen Liu
Lulu Zhang
Fengqi Chen
Yutong Li
Hanke Ma
Wenke Sun
Songyun Ouyang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455095

276 views

Original Research

Published on 11 Apr 2025

A nomogram integrating the clinical and CT imaging characteristics for assessing spread through air spaces in clinical stage IA lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Yantao Yang
Li Li
Huilian Hu
Chen Zhou
Qiubo Huang
Jie Zhao
Yaowu Duan
Wangcai Li
Jia Luo
Jiezhi Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519766

195 views

Editorial

Accepted on 10 Apr 2025

Editorial: Community Series in Novel Biomarkers in Tumor Immunity and Immunotherapy: Volume II

in Cancer Immunity and Immunotherapy

Eyad Elkord
Takaji Matsutani

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608903

Original Research

Accepted on 10 Apr 2025

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines

in Cancer Immunity and Immunotherapy

Cynthia González Muñoz
Rydell Alvarez Arzola
Adanays Calvo Pérez
Milagro de la Caridad Frómeta Campanón
Patricia Hernández Casaña
Aymé Fernández-Calienes Valdés
Patricia Lorenzo-Luaces
Zaima Mazorra Herrera
Tania Crombet Ramos
Mayrel Labrada Mon

Frontiers in Immunology

doi 10.3389/fimmu.2025.1585597

Case Report

Accepted on 10 Apr 2025

Case report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment

in Cancer Immunity and Immunotherapy

Heqi Yang
Yuhang Ma
Chenyan Zhang
Qingqing Leng
Ke Cheng
Chengjian Zhao
Dan Cao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547388

155 views

Systematic Review

Accepted on 10 Apr 2025

Prognostic Significance of Circulating Tumor DNA in Urothelial Carcinoma Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Shufu Hou
Qingping Ma
Haibo Ma
Jing Gao
Dan dan Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1574449

Original Research

Published on 10 Apr 2025

Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker

in Cancer Immunity and Immunotherapy

Ruicheng Wu
Dengxiong Li
Shuxia Zhang
Jie Wang
Qingxin Yu
Dechao Feng
Ping Han

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572108

274 views

Case Report

Published on 10 Apr 2025

Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy

in Cancer Immunity and Immunotherapy

Lynsey M. Claus
Hannah E. Kostan
Marshall E. Hicks
Rony Avritscher
Michael A. Davies

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565355

299 views